Effects of Long-Term Erythropoiesis-Stimulating Agents on Iron Metabolism in Patients on Hemodialysis-Reference-Cited by-同舟云学术

Effects of Long-Term Erythropoiesis-Stimulating Agents on Iron Metabolism in Patients on Hemodialysis

Published:2015-10-20 Issue:6 Volume:19 Page:582-589
ISSN:1744-9979
Container-title:Therapeutic Apheresis and Dialysis
language:en
Short-container-title:Ther Apher Dial

Author:

Onuma Shoko¹,Honda Hirokazu²,Kobayashi Yasuna³,Yamamoto Toshinori³,Michihata Tetsuo⁴,Shibagaki Keigo⁵,Yuza Toshitaka⁵,Hirao Keiichi⁶,Tomosugi Naohisa⁷,Shibata Takanori¹

Affiliation:

1. Division of Nephrology; Department of Medicine; Showa University, School of Medicine; Tokyo Japan

2. Division of Nephrology, Department of Medicine; Showa University Koto Toyosu Hospital; Tokyo Japan

3. Division of Clinical Pharmacy, Department of Pharmacotherapeutics; Showa University, School of Pharmacy; Tokyo Japan

4. Division of Dialysis; Ebara Clinic; Tokyo Japan

5. Division of Dialysis; Shibagaki Dialysis Clinic Jiyugaoka; Tokyo Japan

6. Division of Dialysis; Shibagaki Dialysis Clinic Togoshi; Tokyo Japan

7. Aging Research Unit, Department of Advanced Medicine, Medical Research Institute; Kanazawa Medical University; Kanazawa Japan

Funder

The Kidney Foundation, Japan

Publisher

Wiley

Subject

Nephrology,Hematology

Reference27 articles.

1. Iron and immunity: a double-edged sword;Weiss;Eur J Clin Invest,2002

2. Iron sucrose accelerates early atherogenesis by increasing superoxide production and upregulating adhesion molecules in CKD;Kuo;J Am Soc Nephrol,2014

3. Intravenous iron supplementation practices and short-term risk of cardiovascular events in hemodialysis patients;Kshirsagar;PLoS ONE,2013

4. Iron therapy, advanced oxidation protein products, and carotid artery intima-media thickness in end-stage renal disease;Drüeke;Circulation,2002

5. Intravenous ferric chloride hexahydrate supplementation induced endothelial dysfunction and increased cardiovascular risk among hemodialysis patients;Kuo;PLoS ONE,2012

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential Interactions When Prescribing SGLT2 Inhibitors and Intravenous Iron in Combination in Heart Failure;JACC: Heart Failure;2023-01

2. Clinical significance of a novel reticulocyte‐based erythropoietin resistance index in HD patients: A retrospective study;Therapeutic Apheresis and Dialysis;2021-12-12

3. Monthly Continuous Erythropoietin Receptor Activator Versus Weekly Epoetin-Beta, Similar Hemoglobinization but Different Anisocytosis Degree in Hemodialysis Patients: A Randomized Controlled Trial;Journal of Hematology;2021-12

4. Potential effective treatment of shortening continuous erythropoietin receptor activator treatment interval combined with iron supplementation in hemodialysis patients;Journal of Pharmacological Sciences;2021-09

5. Effects of altitude and recombinant human erythropoietin on iron metabolism: a randomized controlled trial;American Journal of Physiology-Regulatory, Integrative and Comparative Physiology;2021-08-01